Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.28 USD | -0.06% | +1.04% | +31.61% |
05-13 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
05-08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.61% | 2.29B | |
-4.77% | 12.32B | |
-5.19% | 8.07B | |
+30.31% | 5.52B | |
-7.35% | 4.21B | |
-54.91% | 2.99B | |
+13.49% | 2.73B | |
-3.70% | 2.43B | |
-3.55% | 1.89B | |
+3.89% | 1.6B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Insider Sell: Myriad Genetics